p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
OBJECTIVE
The study investigated the pattern of p53 gene mutations and human papillomavirus (HPV) infection concerning their relation to overall survival in patients with oral squamous cell carcinomas of the tongue and floor of the mouth.


METHODS
The presence of HPV infection in 50 patients, and p53 gene mutations (42 patients from the same group) in the tumour specimens were analysed by polymerase chain reaction and single-stranded conformational polymorphism method. The follow-up period ranged from 12 to 48 (median 29) months.


RESULTS
p53 mutations were identified in 11/42 tumours. HPV infection was detected in 32/50 cases, mostly HPV16 (10/32), HPV18 and HPV31 (6/32). A significantly higher incidence of HPV infection was found among smokers (p<0.05) and among patients with poor oral hygiene (p<0.01). The highest incidence of p53 mutations was detected in tumours of histological grade I and nuclear grade III. Patients with p53 mutation or with HPV infection had significantly shorter overall survival when compared with those that were without p53 mutations (p<0.01) or HPV infection (p<0.05). HPV-infected patients with p53 mutation had the worst prognosis when compared with patients with HPV infection only (p<0.01) or with patients negative for both HPV and p53 (p<0.01).


CONCLUSIONS
The results stress once more the importance of HPV for the prognosis of survival of patients with squamous cell carcinoma of lower parts of the oral cavity. The presence of p53 mutations in HPV-infected tumours was associated with an even poorer prognosis for the patients.
Kozomara
Ruzica
R
Clinic of Maxillofacial Surgery, Military Medical Academy, Belgrade, Sebia & Montenegro. k.ruzica@yubc.net
Jović
Nebojsa
N
Magić
Zvonko
Z
Branković-Magić
Mirjana
M
Minić
Vesna
V
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000628:therapy* / Q000821:virology; D005091:Exons / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009060:Mouth Floor / Q000473:pathology; D009062:Mouth Neoplasms / Q000235:genetics / Q000628:therapy* / Q000821:virology; D009154:Mutation / Q000235:genetics*; D009367:Neoplasm Staging; D009910:Oral Hygiene; D027383:Papillomaviridae / Q000502:physiology*; D030361:Papillomavirus Infections / Q000821:virology*; D012907:Smoking; D015996:Survival Rate; D014062:Tongue Neoplasms / Q000235:genetics / Q000628:therapy / Q000821:virology; D016896:Treatment Outcome